Ranking mAb–excipient interactions in biologics formulations by NMR spectroscopy and computational approaches

References

• Rosenberg AS. Effects of protein aggregates: an immunologic perspective. Aaps J. 2006;8(3):E501–13. doi:10.1208/aapsj080359.
   PubMed Web of Science ®Google Scholar
• Moussa EM, Panchal JP, Moorthy BS, Blum JS, Joubert MK, Narhi LO, Topp EM. Immunogenicity of therapeutic protein aggregates. J Pharm Sci. 2016;105(2):417–30. doi:10.1016/j.xphs.2015.11.002.
   PubMed Web of Science ®Google Scholar
• Parkins DA, Lashmar UT. The formulation of biopharmaceutical products. Pharm Sci Technolo Today. 2000;3(4):129–37. doi:10.1016/S1461-5347(00)00248-0.
   PubMedGoogle Scholar
• Akers MJ. Excipient-drug interactions in parenteral formulations. J Pharm Sci. 2002;91(11):2283–300. doi:10.1002/jps.10154.
   PubMed Web of Science ®Google Scholar
• Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein–excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63(13):1118–59. doi:10.1016/j.addr.2011.07.006.
   PubMed Web of Science ®Google Scholar
• Stoll VS, Blanchard JS. [4] buffers: principles and practice. In Deutscher MP, ed. Methods Enzymol: Academic Press; 1990. p. pp. 24–38.
   Google Scholar
• Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505–23. doi:10.1080/10837450701481157.
   PubMed Web of Science ®Google Scholar
• Chang LL, Pikal MJ. Mechanisms of protein stabilization in the solid state. J Pharm Sci. 2009;98(9):2886–908. doi:10.1002/jps.21825.
   PubMed Web of Science ®Google Scholar
• Kumar R. Role of naturally occurring osmolytes in protein folding and stability. Arch Biochem Biophys. 2009;491(1–2):1–6. doi:10.1016/j.abb.2009.09.007.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Tsumoto K, Kita Y, Chang B, Ejima D. Biotechnology applications of amino acids in protein purification and formulations. Amino Acids. 2007;33(4):587–605. doi:10.1007/s00726-007-0506-3.
   PubMed Web of Science ®Google Scholar
• Kerwin B. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci. 2008;97(8):2924–35. doi:10.1002/jps.21190.
   PubMed Web of Science ®Google Scholar
• Dave VS, Haware RV, Sangave NA, Sayles M, Popielarczyk M. Drug-excipient compatibility studies in formulation development: current trends and techniques. AAPS FDD Sec Newslett. 2015;9–15.
   Google Scholar
• Patel PA, Ahir K, Patel VB, Manani L, Patel C. Drug-excipient compatibility studies: first step for dosage form development. J Pharm Innov. 2015;4:14–20.
   Google Scholar
• Bee JS, Chiu D, Sawicki S, Stevenson JL, Chatterjee K, Freund E, Carpenter JF, Randolph TW. Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies. J Pharm Sci. 2009;98(9):3218–38. doi:10.1002/jps.21768.
   PubMed Web of Science ®Google Scholar
• Kopp MRG, Perez AMW, Zucca MV, Palmiero UC, Friedrichsen B, Lorenzen N, Arosio P. An accelerated surface-mediated stress assay of antibody instability for developability studies. MAbs. 2020;12(1):12. doi:10.1080/19420862.2020.1815995.
   Web of Science ®Google Scholar
• Roughton BC, Iyer LK, Bertelsen E, Topp EM, Camarda KV. Protein aggregation and lyophilization: protein structural descriptors as predictors of aggregation propensity. Comput Chem Eng. 2013;58:369–77. doi:10.1016/j.compchemeng.2013.07.008.
   PubMed Web of Science ®Google Scholar
• Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1–2):1–60. doi:10.1016/S0378-5173(00)00423-3.
   PubMed Web of Science ®Google Scholar
• Butreddy A, Janga KY, Ajjarapu S, Sarabu S, Dudhipala N. Instability of therapeutic proteins - an overview of stresses, stabilization mechanisms and analytical techniques involved in lyophilized proteins. Int J Biol Macromol. 2021;167:309–25. doi:10.1016/j.ijbiomac.2020.11.188.
   PubMed Web of Science ®Google Scholar
• Kim NA, Thapa R, Jeong SH. Preferential exclusion mechanism by carbohydrates on protein stabilization using thermodynamic evaluation. Int J Biol Macromol. 2018;109:311–22. doi:10.1016/j.ijbiomac.2017.12.089.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Prestrelski SJ, Kenney WC, Carpenter JF. Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev. 2001;46(1–3):307–26. doi:10.1016/s0169-409x(00)00144-7.
   PubMed Web of Science ®Google Scholar
• Avanti C, Saluja V, van Streun EL, Frijlink HW, Hinrichs WL, Permyakov EA. Stability of lysozyme in aqueous extremolyte solutions during heat shock and accelerated thermal conditions. PLos One. 2014;9(1):e86244. doi:10.1371/journal.pone.0086244.
   PubMed Web of Science ®Google Scholar
• Souillac PO, Middaugh CR, Rytting JH. Investigation of protein/carbohydrate interactions in the dried state. 2. Diffuse reflectance FTIR studies. Int J Pharm. 2002;235(1–2):207–18. doi:10.1016/s0378-5173(01)00987-5.
   PubMedGoogle Scholar
• Mayer M, Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc. 2001;123(25):6108–17. doi:10.1021/ja0100120.
   PubMed Web of Science ®Google Scholar
• Kemper S, Patel MK, Errey JC, Davis BG, Jones JA, Claridge TDW. Group epitope mapping considering relaxation of the ligand (GEM-CRL): including longitudinal relaxation rates in the analysis of saturation transfer difference (STD) experiments. J Magn Reson. 2010;203(1):1–10. doi:10.1016/j.jmr.2009.11.015.
   PubMed Web of Science ®Google Scholar
• Joshi S, Maharana C, Rathore AS. An application of nano differential scanning fluorimetry for higher order structure assessment between mAb originator and biosimilars: trastuzumab and rituximab as case studies. J Pharm Biomed Anal. 2020;186:113270. doi:10.1016/j.jpba.2020.113270.
   PubMed Web of Science ®Google Scholar
• Svilenov HL, Kulakova A, Zalar M, Golovanov AP, Harris P, Winter G. Orthogonal techniques to study the effect of pH, sucrose, and arginine salts on monoclonal antibody physical stability and aggregation during long-term storage. J Pharm Sci. 2020;109(1):584–94. doi:10.1016/j.xphs.2019.10.065.
   PubMed Web of Science ®Google Scholar
• Bailly M, Mieczkowski C, Juan V, Metwally E, Tomazela D, Baker J, Uchida M, Kofman E, Raoufi F, Motlagh S, et al. Predicting antibody developability profiles through early stage discovery screening. MAbs. 2020;12(1):1743053. doi:10.1080/19420862.2020.1743053.
   PubMed Web of Science ®Google Scholar
• Angulo J, Enríquez-Navas PM, Nieto PM. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. Chemistry. 2010;16(26):7803–12. doi:10.1002/chem.200903528.
   PubMed Web of Science ®Google Scholar
• Goel H, Hazel A, Ustach VD, Jo S, Yu W, MacKerell AD. Rapid and accurate estimation of protein–ligand relative binding affinities using site-identification by ligand competitive saturation. Chem Sci. 2021;12(25):8844–58. doi:10.1039/D1SC01781K.
   PubMedGoogle Scholar
• Viegas A, Manso J, Nobrega FL, Cabrita EJ. Saturation-transfer difference (STD) NMR: a simple and fast method for ligand screening and characterization of protein binding. J Chem Educ. 2011;88(7):990–94. doi:10.1021/ed101169t.
   Web of Science ®Google Scholar
• Buchanan CJ, Gaunt B, Harrison PJ, Yang Y, Liu J, Khan A, Giltrap AM, Le Bas A, Ward PN, Gupta K, et al. Pathogen-sugar interactions revealed by universal saturation transfer analysis. Science. 2022;377(6604):eabm3125. doi:10.1126/science.abm3125.
   PubMed Web of Science ®Google Scholar
• Svilenov H, Kopp K, Golovanov A, Winter G, Zalard M. Insights into the stabilization of interferon alpha by two surfactants revealed by STD-NMR spectroscopy. J Pharm Sci. 2022:1–7. doi:10.1016/j.xphs.2022.10.013.
   Web of Science ®Google Scholar
• Zalar M, Svilenov H, Golovanova A. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins. Eur J Pharm Biopharm. 2020;151:127–36. doi:10.1016/j.ejpb.2020.04.002.
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). 2020. 09. Chemical computing group ULC, 1010 Sherbrooke St West, suite #910. Montreal, QC, Canada H3A 2R7; 2022. http://www.chemcomp.com
   Google Scholar
• Case DA, Belfon K, Ben-Shalom IY, Berryman JT, Brozell SR, Cerutti DS, Cheatham TE III, Cisneros GA, Cruzeiro VWD, Darden TA, Duke RE, Giambasu G, Gilson MK, Gohlke H, Goetz AW, Harris R, Izadi S, Izmailov SA, Kasavajhala K, Kaymak MC, King E, Kovalenko A, Kurtzman T, Lee TS, LeGrand S, Li P, Lin C, Liu J, Luchko T, Luo R, Machado M, Man V, Manathunga M, Merz KM, Miao Y, Mikhailovskii O, Monard G, Nguyen H, O’Hearn KA, Onufriev A, Pan F, Pantano S, Qi R, Rahnamoun A, Roe DR, Roitberg A, Sagui C, Schott-Verdugo S, Shajan A, Shen J, Simmerling CL, Skrynnikov NR, Smith J, Swails J, Walker RC, Wang J, Wang J, Wei H, Wolf RM, Wu X, Xiong Y, Xue Y, York DM, Zhao S, and Kollman PA. Amber 2022. San Francisco: University of California; 2022.
   Google Scholar
• Phillips JC, Hardy DJ, Maia JDC, Stone JE, Ribeiro JV, Bernardi RC, Buch R, Fiorin G, Hénin J, Jiang W, et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys. 2020;153(4):044130. doi:10.1063/5.0014475.
   PubMed Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1). 33-8. doi:10.1016/0263-7855(96)00018-5.
   PubMedGoogle Scholar
• Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25. doi:10.1016/j.softx.2015.06.001.
   Google Scholar
• Somani S, Jo S, Thirumangalathu R, Rodrigues D, Tanenbaum LM, Amin K, MacKerell AD Jr., Thakkar SV. Toward biotherapeutics formulation composition engineering using site-identification by ligand competitive saturation (SILCS). J Pharm Sci. 2021;110:1103–10. doi:10.1016/j.xphs.2020.10.051.
   PubMed Web of Science ®Google Scholar
• Raman EP, Yu W, Guvench O, MacKerell AD. Reproducing crystal binding modes of ligand functional groups using site-identification by ligand competitive saturation (SILCS) simulations. J Chem Inf Model. 2011;51:877–96. doi:10.1021/ci100462t.
   PubMed Web of Science ®Google Scholar
• Raman EP, Yu W, Lakkaraju SK, MacKerell AD Jr. Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. J Chem Inf Model. 2013;53:3384–98. doi:10.1021/ci4005628.
   PubMed Web of Science ®Google Scholar
• Ustach VD, Lakkaraju SK, Jo S, Yu W, Jiang W, MacKerell AD. Optimization and evaluation of site-identification by ligand competitive saturation (SILCS) as a tool for target-based ligand optimization. J Chem Inf Model. 2019;59:3018–35. doi:10.1021/acs.jcim.9b00210.
   PubMed Web of Science ®Google Scholar
• Best RB, Zhu X, Shim J, Lopes PE, Mittal J, Feig M, Mackerell AD Jr. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. J Chem Theory Comput. 2012;8:3257–73. doi:10.1021/ct300400x.
   PubMed Web of Science ®Google Scholar
• Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, Grubmüller H, MacKerell AD. Charmm36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017;14:71–73. doi:10.1038/nmeth.4067.
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, Darian E, Guvench O, Lopes P, Vorobyov I, et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem. 2010;31:671–90. doi:10.1002/jcc.21367.
   PubMed Web of Science ®Google Scholar
• Durell SR, Brooks BR, Ben-Naim A. Solvent-induced forces between two hydrophilic groups. J Phys Chem. 1994;98:2198–202.
   Web of Science ®Google Scholar
• Wu D, Minton AP. Quantitative characterization of the interaction between sucrose and native proteins via static light scattering. J Phys Chem B. 2013;117:111–17. doi:10.1021/jp308880v.
   PubMed Web of Science ®Google Scholar
• Holloway L, Roche A, Marzouk S, Uddin S, Ke P, Ekizoglou S, Curtis R. Determination of protein-protein interactions at high co-solvent concentrations using static and dynamic light scattering. J Pharm Sci. 2020;109:2699–709. doi:10.1016/j.xphs.2020.05.023.
   PubMed Web of Science ®Google Scholar